Executive Master - Strategy and Management of Health Industries (This program is designed for high-potential managers ready to take on new responsibilities in pharma)
2013 - 2015
Pierre and Marie Curie University (Paris VI)
PhD (Molecular and Cellular Developmental Biology)
1994 - 1998
Pierre and Marie Curie University (Paris VI)
Master (Cellular Biology, Genetics and Development)
1993 - 1994
Pierre and Marie Curie University (Paris VI)
Bachelor (Physiology and Cellular Biology)
1992 - 1993
Cefira
(Pediatric Development)
2010
DIA (Drug Information Association)
(European Regulatory Affairs)
2009
Mylene Skalski's Skills
Toxicology
Drug Discovery
Oncology
RT-PCR
Life Sciences
Lifesciences
Drug Development
Biotechnology
In Vivo
CRO
Mylene Skalski's Summary
Mylene Skalski, based in Paris, FR, is currently a Study Director and Scientific Project Leader in Safety Assessment at Covance, bringing experience from previous roles at Covance, sanofi-aventis, sanofi-synthelabo and Denis Diderot University (Paris VII) - Development Biology Laboratory. Mylene Skalski holds a 2013 - 2015 Executive Master - Strategy and Management of Health Industries in This program is designed for high-potential managers ready to take on new responsibilities in pharma @ ESSEC Business School. With a robust skill set that includes Toxicology, Drug Discovery, Oncology, RT-PCR, Life Sciences and more, Mylene Skalski contributes valuable insights to the industry. Mylene Skalski has 1 email on RocketReach.